BEAM - Beam Therapeutics Inc.

27.44
0.220   0.802%

Share volume: 2,231,891
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.44%

PREVIOUS CLOSE
CHG
CHG%
$27.22
0.22
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-07-2024 08-06-2024 11-05-2024 02-25-2025 05-06-2025 11-04-2025 02-24-2026
Total revenue 7.410 M 11.772 M 14.269 M 30.067 M 7.470 M 9.698 M 114.109 M
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 7.410 M 11.772 M 14.269 M 30.067 M 7.470 M 9.698 M 114.109 M
    58.87% 21.21% 110.72% -75.16% 29.83% 1,076.62%  
Operating expenses 111.542 M 116.667 M 120.773 M 130.104 M 126.756 M 136.509 M 131.554 M
Selling general and admin 26.724 M 29.626 M 26.515 M 28.660 M 27.940 M 26.740 M 32.279 M
Research and development 84.818 M 87.041 M 94.258 M 101.444 M 98.816 M 109.769 M 99.275 M
Total expenses 111.542 M 116.667 M 120.773 M 130.104 M 126.783 M 136.509 M 131.499 M
    4.59% 3.52% 7.73% -2.55% 7.67% -3.67%  
Operating income -104.132 M -104.895 M -106.504 M -100.037 M -119.286 M -126.811 M -17.445 M
Ebit -110.518 M -105.202 M -108.795 M -101.282 M -119.107 M -123.631 M -21.544 M
Pretax income 0.000 -91.012 M -96.668 M -189.023 M -109.270 M -112.728 M 244.297 M
    inf% 6.21% 95.54% -42.19% 3.16% -316.71%  
Income tax 0.000 39.000 K 0.000 0.000 0.000 0.000 0.000
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -98.669 M -91.051 M -96.668 M -90.354 M -109.270 M -112.728 M 244.297 M
    7.72% -6.17% 6.53% -20.94% -3.16% 316.71%